These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 20962623

  • 1. Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography.
    Acikel S, Muderrisoglu H, Yildirir A, Aydinalp A, Sade E, Bayraktar N, Bal U, Ozin B.
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):750-7. PubMed ID: 20962623
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
    Ozhan H, Erden I, Ordu S, Aydin M, Caglar O, Basar C, Yalcin S, Alemdar R.
    Angiology; 2010 Oct; 61(7):711-4. PubMed ID: 20395226
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A, Maioli M, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Manzone C, Amato M, Bellandi F.
    Am J Cardiol; 2010 Feb 01; 105(3):288-92. PubMed ID: 20102936
    [Abstract] [Full Text] [Related]

  • 4. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G, Ricottini E, Nusca A, Colonna G, Pasceri V, D'Ambrosio A, Montinaro A, Di Sciascio G.
    Am J Cardiol; 2011 Jul 01; 108(1):1-7. PubMed ID: 21529740
    [Abstract] [Full Text] [Related]

  • 5. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH.
    Int J Cardiol; 2010 Feb 04; 138(3):239-45. PubMed ID: 18793808
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G, Nusca A, Chello M, Pasceri V, D'Ambrosio A, Vetrovec GW, Di Sciascio G.
    Am J Cardiol; 2008 Feb 01; 101(3):279-85. PubMed ID: 18237585
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention.
    Li W, Fu X, Wang Y, Li X, Yang Z, Wang X, Geng W, Gu X, Hao G, Jiang Y, Fan W, Wu W, Li S.
    Cardiology; 2012 Feb 01; 122(3):195-202. PubMed ID: 22854323
    [Abstract] [Full Text] [Related]

  • 8. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.
    Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL.
    N Engl J Med; 2003 Oct 02; 349(14):1333-40. PubMed ID: 14523141
    [Abstract] [Full Text] [Related]

  • 9. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.
    Am Heart J; 2003 Dec 02; 146(6):E23. PubMed ID: 14661012
    [Abstract] [Full Text] [Related]

  • 10. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
    Merkle M, Sauter M, Argirov M, Wörnle M.
    Ren Fail; 2010 Jan 02; 32(1):85-90. PubMed ID: 20113272
    [Abstract] [Full Text] [Related]

  • 11. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K, Adreanides E, Demerouti E, Gkouziouta A, Manginas A, Pavlides G, Voudris V, Cokkinos DV.
    Circulation; 2009 Nov 03; 120(18):1793-9. PubMed ID: 19841299
    [Abstract] [Full Text] [Related]

  • 12. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
    Zhang J, Fu X, Jia X, Fan X, Gu X, Li S, Wu W, Fan W, Su J, Hao G, Jiang Y, Xue L.
    Acta Radiol; 2010 Jul 03; 51(6):641-8. PubMed ID: 20438292
    [Abstract] [Full Text] [Related]

  • 13. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M.
    Am J Cardiol; 2007 Sep 01; 100(5):781-6. PubMed ID: 17719320
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A new protocol using sodium bicarbonate for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
    Motohiro M, Kamihata H, Tsujimoto S, Seno T, Manabe K, Isono T, Sutani Y, Yuasa F, Iwasaka T.
    Am J Cardiol; 2011 Jun 01; 107(11):1604-8. PubMed ID: 21420053
    [Abstract] [Full Text] [Related]

  • 16. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial).
    Kaya A, Kurt M, Tanboğa IH, Işik T, Ekinci M, Aksakal E, Kaya Y, Topçu S, Sevimli S.
    Acta Cardiol; 2013 Oct 01; 68(5):489-94. PubMed ID: 24283110
    [Abstract] [Full Text] [Related]

  • 17. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
    Toso A, Leoncini M, Maioli M, Gallopin M, Tedeschi D, Amato M, Bellandi F.
    J Cardiovasc Med (Hagerstown); 2011 May 01; 12(5):318-21. PubMed ID: 21045713
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
    Hermsen ED, Maiefski M, Florescu MC, Qiu F, Rupp ME.
    Pharmacotherapy; 2009 Jun 01; 29(6):649-55. PubMed ID: 19476418
    [Abstract] [Full Text] [Related]

  • 19. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xinwei J, Xianghua F, Jing Z, Xinshun G, Ling X, Weize F, Guozhen H, Yunfa J, Weili W, Shiqiang L.
    Am J Cardiol; 2009 Aug 15; 104(4):519-24. PubMed ID: 19660605
    [Abstract] [Full Text] [Related]

  • 20. Preoperative creatinine clearance as a predictor of short-term outcomes after cardiac surgery: a cohort study for the comparison between the Cockroft-Gault and modification of diet in renal disease formulae.
    Luciani R, Lazzarino AI, Capuano F, Benedetto U, Goracci M, Pirozzi N, Sinatra R.
    J Cardiovasc Med (Hagerstown); 2010 Apr 15; 11(4):271-5. PubMed ID: 20072000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.